Cleared Traditional

K221886 - Sublime Microcatheter

K221886 is an FDA 510(k) clearance for Sublime Microcatheter, manufactured by Surmodics,Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 107-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
107d
Days
Class 2
Risk

K221886 is an FDA 510(k) clearance for the Sublime Microcatheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Surmodics,Inc. (Eden Prairie, US). The FDA issued a Cleared decision on October 14, 2022 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Surmodics,Inc. devices

FDA 510(k) Submission Details - K221886

510(k) Number K221886 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 2022
Decision Date October 14, 2022
Days to Decision 107 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d faster than avg
Panel avg: 125d · This submission: 107d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 619
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K221886.
SelectSite C304 Deflectable Catheter System, C315 Delivery System
K223178 · Medtronic · Nov 2022
Attain Command + SureValve Delivery System, Attain Select II + SureValve delivery system
K222873 · Medtronic · Nov 2022
Houdini Cross Support Catheter
K213466 · Cruzar Medsystems, Inc. · Oct 2022
SOFIA 88 Catheter
K214024 · MicroVention, Inc. · Sep 2022
GuideLiner Coast, 5.5F (5270)
K220647 · Vascular Solutions, LLC · Aug 2022
091 Balloon Guide Catheter
K220331 · Inneuroco, Inc. · Jul 2022